Evidence map›Paper›PMID 39331623›Full record

ArticlePloS one2024

Efficient population size of urban agglomerations in the Yangtze River Economic Belt from a financial perspective.

Long Xiao

Abstract read
In one paragraph

Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Long XiaoSchool of Media and Exhibition, Fujian Business University, Fuzhou, China.ORCID 0009-0000-2749-0394

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Urban agglomerations, such as the Yangtze River Delta, Yangtze River Middle Reaches, and Chengdu-Chongqing regions, play a crucial role in driving China's regional economic development. While previous studies have focused on economic and social aspects, the fiscal dimension of urban agglomerations remains underexplored. This study addresses this gap by investigating the relationship between population size and fiscal efficiency in these three major urban agglomerations along the Yangtze River Economic Belt (YREB).We introduce the concept of fiscal efficiency based on revenue and expenditure and select relevant indices, such as efficient population size and fiscal self-reliance. Using statistical data from 2017 to 2019, we employ curve regression analysis in SPSS to estimate the efficient population sizes of these urban agglomerations and examine differences in financial efficiency over time and space. Our analysis reveals that cities with populations over 10 million hinder fiscal efficiency in the Yangtze River Delta, those with 3-5 and 5-10 million in the Yangtze River Middle Reaches, and those with 5-10 and 1-5 million in the Chengdu-Chongqing urban agglomerations. The maximum financially efficient population sizes are estimated at 648 million for the Yangtze River Delta, 308 million for the Yangtze River Middle Reaches, and 320 million for the Chengdu-Chongqing urban agglomerations. Considering various fiscal indicators, all three agglomerations demonstrate varying degrees of efficiency. The innovation of this study lies in the interdisciplinary approach, integrating finance, demography, urban planning, and regional economics. By analyzing population size from a fiscal perspective, we provide a novel theoretical framework and analytical tool for policymakers. This study highlights the importance of fiscal balance and population optimization in urban agglomerations, contributing to regional coordinated development and sustainable growth.

Indexed as

Population DensityRiversChinaCitiesEconomic DevelopmentHumansUrbanizationUrban Population

Identifiers

PMID39331623
PMCPMC11432864

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.